icoMetrix Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 64

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

icoMetrix General Information

Description

Developer of AI-based software and technology intended for the analysis of brain MRI images. The company's cloud-based brain magnetic resonance imaging software extracts clinically meaningful information from brain MRI and CT scans of patients with neurological disorders, enabling physicians to improve efficiency in the diagnosis and monitoring of multiple sclerosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Outcome Management (Healthcare)
Primary Office
  • Kolonel Begaultlaan 1b / 12
  • 3012 Leuven
  • Belgium
+32 016 00 00 00

icoMetrix Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

icoMetrix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private 01-Apr-2021 000.00 Completed Generating Revenue
4. Later Stage VC 30-Apr-2020 00000 000.00 00.000 Completed Generating Revenue
3. Later Stage VC (Series B) 14-May-2019 000.00 000.00 0000 Completed Generating Revenue
2. Later Stage VC 12-Jan-2016 $2.18M $2.25M Completed Generating Revenue
1. Early Stage VC 01-Jan-2011 $66.1K $66.1K Completed Startup
To view icoMetrix’s complete valuation and funding history, request access »

icoMetrix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference C 00,000 00.00 00.00 00 00.00 0.000
Class B 00,000 00.00 00.00 00 00.00 0.000
Class A 00,000 00.00 00.00 00 00.00 00.000
Preference C 000,000 000.00 000.00 00 000.00 00.000
Preference C 00,000 000.00 000.00 00 000.00 0.000
Pref 00,000 000.00 000.00 00 000.00 000
Pref 00,000 000.00 000.00 00 000.00 0.000
Profit Share C 35,640 $3.24 $3.24 1x $3.24 5.92%
Pref 29,713 $5.49 $5.49 1x $5.49 4.93%
To view icoMetrix’s complete cap table history, request access »

icoMetrix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of AI-based software and technology intended for the analysis of brain MRI images. The company's cloud-based b
Decision/Risk Analysis
Leuven, Belgium
64 As of 2022
000.00
00000000000 000.00

0000 0

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaec
0000000000000 00000000
Tel Aviv, Israel
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

000000

d minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. D
0000000 0000000000 (0000000000)
Philadelphia, PA
00 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

icoMetrix Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MaxQ AI Venture Capital-Backed Tel Aviv, Israel 00 000.00 00000000000 000.00
000000 0000000 Venture Capital-Backed Philadelphia, PA 00 00.000 0000000000 0 00.000
00000 Venture Capital-Backed Tel Aviv, Israel 000 00000 00000000000 00000
000000 0000000 Private Equity-Backed Oxford, United Kingdom 00 00.00 0000000 0000 00.00
0000000000 Venture Capital-Backed La Jolla, CA 00 00000000000
You’re viewing 5 of 26 competitors. Get the full list »

icoMetrix Patents

icoMetrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3624058-A1 Method and system of analyzing symmetry from image data Withdrawn 17-Sep-2018 00000000 0
AU-2019345098-A1 Analyzing symmetry in image data Pending 17-Sep-2018 00000000
EP-3853814-A1 Analyzing symmetry in image data Pending 17-Sep-2018 00000000
ES-2685977-T3 Method and system to analyze image data Active 09-Sep-2014 0000000000
US-10198815-B2 Method and system for analyzing image data Active 09-Sep-2014 G06T7/0014
To view icoMetrix’s complete patent history, request access »

icoMetrix Executive Team (10)

Name Title Board Seat Contact Info
Wim Van Hecke Ph.D Co-Founder, Chief Executive Officer & Board Member
Michiel Roels Chief Financial Officer & Executive of Human Resources
Dirk Smeets Ph.D Chief Technology Officer
Jennifer Young Chief Commercial Officer
Jan Verheyden Vice President Strategic Partnerships
You’re viewing 5 of 10 executive team members. Get the full list »

icoMetrix Board Members (14)

Name Representing Role Since
André Oosterlinck Ph.D Self Board Member 000 0000
Heather Roxborough Ph.D Optum Ventures Board Member 000 0000
Herman Verrelst Self Board Member 000 0000
Jay Miller Self Board Member 000 0000
Katrin Geyskens Capricorn Partners Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

icoMetrix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

icoMetrix Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Forestay Capital Venture Capital Minority 000 0000 000000 0
HERAN Partners Venture Capital Minority 000 0000 000000 0
Optum Ventures Corporate Venture Capital Minority 000 0000 000000 0
Annie Vereecken Angel (individual) Minority 000 0000 000000 0
Antwerp University Hospital Corporation Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »